Seroreversion in AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorder

被引：0
|
作者：
Kuempfel, Tania [1 ]
Oswald, Eva [1 ]
Havla, Joachim [1 ]
Engels, Daniel [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, Munich, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1032/2043
引用
收藏
页码：670 / 670
页数：1
相关论文
共 50 条
  • [21] Distinction of double seronegative neuromyelitis optica spectrum disease from AQP4-IgG seropositive and MOG-IgG seropositive cases in Asian patients
    Kim, H. W.
    Lee, E. J.
    Lee, S.
    Kim, H.
    Kim, S. K.
    Kim, S.
    Choi, L.
    Lim, Y. M.
    Kim, K. K.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 587 - 587
  • [22] AQP4-IgG antibodies as biomarkers for early diagnosis of neuromyelitis optica spectrum disorders
    Mader, Simone
    Deisenhammer, Florian
    Reindl, Markus
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2010, 34 (06): : 337 - 342
  • [23] Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
    Palace, Jacqueline
    Lin, Dan-Yu
    Zeng, Donglin
    Majed, Masoud
    Elsone, Liene
    Hamid, Shand
    Messina, Silvia
    Misu, Tatsuro
    Sagen, Jessica
    Whittam, Daniel
    Takai, Yoshiki
    Leite, Maria Isabel
    Weinshenker, Brian
    Cabre, Philippe
    Jacob, Anu
    Nakashima, Ichiro
    Fujihara, Kazuo
    Pittock, Sean J.
    BRAIN, 2019, 142 : 1310 - 1323
  • [24] Determinants of relapse risk in AQP4-IgG and seronegative neuromyelitis optica spectrum disorder: an international cohort study
    Siriratnam, Pakeeran
    Sanfilippo, Paul
    van der Walt, Anneke
    Sharmin, Sifat
    Kalincik, Tomas
    Jokubaitis, Vilija
    Butzkueven, Helmut
    Huda, Saif
    Monif, Mastura
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 140 - 140
  • [25] Safety and efficacy of plasma exchange treatment in children with AQP4-IgG positive neuromyelitis optica spectrum disorder
    Li, Zhichao
    Wan, Lin
    Liu, Xinting
    Wang, Jing
    Shi, Xiuyu
    Zhou, Huanfen
    Xu, Quangang
    Wei, Shihui
    Yang, Guang
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [26] Delusions and Hallucinations in Neuromyelitis Optica Spectrum Disorder with AQP4-IgG: A Case-Based Systematic Review
    Delgado-Garcia, Guillermo
    Alberto Sanchez-Garza, Jose
    Ramirez-Bermudez, Jesus
    Rivas-Alonso, Veronica
    Flores-Rivera, Jose
    Corona-Vazquez, Teresa
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 117 - 117
  • [27] Causes of death in AQP4-IgG neuromyelitis optica spectrum disorder (NMOSD) in the United Kingdom NMOSD Service
    Gibbons, E.
    Everett, R.
    Whittam, D.
    Karthikeayan, V.
    Messina, S.
    Mutch, K.
    Kelly, P.
    Linaker, S.
    Reeve, S.
    Leite, M. I.
    Huda, S.
    Palace, J.
    Jacob, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 588 - 589
  • [28] Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
    Maillart, Elisabeth
    Renaldo, Florence
    Papeix, Caroline
    Deiva, Kumaran
    Bonheur, Julie
    Kwon, Teresa
    Boespflug-Tanguy, Odile
    Germanaud, David
    Marignier, Romain
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (03):
  • [29] Neuromyelitis optica spectrum disorders: comparison of clinical and MRI characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands
    van Pelt, E. D.
    Wong, Y. Y.
    Ketelslegers, I. A.
    Hamann, D.
    Hintzen, R. Q.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 372 - 372
  • [30] Efficacy and Safety of Satralizumab in Adults with AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from the Phase 3 SAkura Studies
    Bennet, J. L.
    Fox, E.
    Greenberg, B. M.
    Weinshenker, B. G.
    Blondeau, K.
    Weber, K.
    Gholizadeh, S.
    Stokmaier, D.
    von Budingen, H.
    Traboulsee, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 80 - 80
12345